SWOG S1500

Primary Category:

Treatment Protocols

Disease Category:

Renal, Renal Metastatic

Status:

Open

A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)

 

NCT#02761057

Partial permanent closure for Arm 3 and Arm 4 effective 12/05/18.